nodes	percent_of_prediction	percent_of_DWPC	metapath
Dihydrotachysterol—VDR—prostate cancer	0.867	1	CbGaD
Dihydrotachysterol—VDR—Ovarian Infertility Genes—BMPR1B—prostate cancer	0.00531	0.0507	CbGpPWpGaD
Dihydrotachysterol—VDR—prostate gland—prostate cancer	0.00462	0.229	CbGeAlD
Dihydrotachysterol—VDR—Drug Induction of Bile Acid Pathway—SULT2A1—prostate cancer	0.00357	0.034	CbGpPWpGaD
Dihydrotachysterol—VDR—Vitamin D Metabolism—RXRA—prostate cancer	0.00343	0.0327	CbGpPWpGaD
Dihydrotachysterol—VDR—epithelium—prostate cancer	0.0034	0.169	CbGeAlD
Dihydrotachysterol—VDR—renal system—prostate cancer	0.00315	0.156	CbGeAlD
Dihydrotachysterol—VDR—urethra—prostate cancer	0.00309	0.154	CbGeAlD
Dihydrotachysterol—VDR—Drug Induction of Bile Acid Pathway—CYP3A4—prostate cancer	0.00251	0.024	CbGpPWpGaD
Dihydrotachysterol—VDR—bone marrow—prostate cancer	0.00238	0.118	CbGeAlD
Dihydrotachysterol—VDR—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCG5—prostate cancer	0.00238	0.0227	CbGpPWpGaD
Dihydrotachysterol—VDR—Validated transcriptional targets of TAp63 isoforms—GDF15—prostate cancer	0.00225	0.0215	CbGpPWpGaD
Dihydrotachysterol—VDR—Validated transcriptional targets of deltaNp63 isoforms—RUNX1—prostate cancer	0.00224	0.0214	CbGpPWpGaD
Dihydrotachysterol—VDR—Retinoic acid receptors-mediated signaling—NCOA3—prostate cancer	0.00213	0.0203	CbGpPWpGaD
Dihydrotachysterol—VDR—testis—prostate cancer	0.00204	0.101	CbGeAlD
Dihydrotachysterol—VDR—Ovarian Infertility Genes—MLH1—prostate cancer	0.00185	0.0176	CbGpPWpGaD
Dihydrotachysterol—VDR—Retinoic acid receptors-mediated signaling—NCOA2—prostate cancer	0.00178	0.017	CbGpPWpGaD
Dihydrotachysterol—VDR—RXR and RAR heterodimerization with other nuclear receptor—NCOA1—prostate cancer	0.00168	0.016	CbGpPWpGaD
Dihydrotachysterol—VDR—RXR and RAR heterodimerization with other nuclear receptor—RXRA—prostate cancer	0.0016	0.0152	CbGpPWpGaD
Dihydrotachysterol—VDR—Ovarian Infertility Genes—ESR2—prostate cancer	0.00154	0.0147	CbGpPWpGaD
Dihydrotachysterol—VDR—Regulation of nuclear SMAD2/3 signaling—LAMC1—prostate cancer	0.00151	0.0145	CbGpPWpGaD
Dihydrotachysterol—VDR—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2E1—prostate cancer	0.0015	0.0143	CbGpPWpGaD
Dihydrotachysterol—VDR—Retinoic acid receptors-mediated signaling—NCOA1—prostate cancer	0.0015	0.0143	CbGpPWpGaD
Dihydrotachysterol—VDR—lymph node—prostate cancer	0.00148	0.0732	CbGeAlD
Dihydrotachysterol—VDR—Regulation of nuclear SMAD2/3 signaling—RUNX1—prostate cancer	0.00145	0.0139	CbGpPWpGaD
Dihydrotachysterol—VDR—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP3A4—prostate cancer	0.00144	0.0138	CbGpPWpGaD
Dihydrotachysterol—VDR—Ovarian Infertility Genes—EGR1—prostate cancer	0.00144	0.0138	CbGpPWpGaD
Dihydrotachysterol—VDR—Retinoic acid receptors-mediated signaling—RXRA—prostate cancer	0.00142	0.0136	CbGpPWpGaD
Dihydrotachysterol—VDR—Validated transcriptional targets of deltaNp63 isoforms—IGFBP3—prostate cancer	0.00141	0.0134	CbGpPWpGaD
Dihydrotachysterol—VDR—Ovarian Infertility Genes—CYP19A1—prostate cancer	0.0014	0.0134	CbGpPWpGaD
Dihydrotachysterol—VDR—Ovarian Infertility Genes—CCND2—prostate cancer	0.0014	0.0134	CbGpPWpGaD
Dihydrotachysterol—VDR—Nuclear Receptors—ESR2—prostate cancer	0.00134	0.0128	CbGpPWpGaD
Dihydrotachysterol—VDR—Direct p53 effectors—CD82—prostate cancer	0.00129	0.0123	CbGpPWpGaD
Dihydrotachysterol—VDR—Validated transcriptional targets of deltaNp63 isoforms—TOP2A—prostate cancer	0.00129	0.0123	CbGpPWpGaD
Dihydrotachysterol—VDR—Validated transcriptional targets of TAp63 isoforms—OGG1—prostate cancer	0.00127	0.0121	CbGpPWpGaD
Dihydrotachysterol—VDR—Validated transcriptional targets of TAp63 isoforms—IGFBP3—prostate cancer	0.00126	0.012	CbGpPWpGaD
Dihydrotachysterol—VDR—Direct p53 effectors—FOXA1—prostate cancer	0.00124	0.0118	CbGpPWpGaD
Dihydrotachysterol—VDR—RXR and RAR heterodimerization with other nuclear receptor—PPARA—prostate cancer	0.00122	0.0116	CbGpPWpGaD
Dihydrotachysterol—VDR—Nuclear Receptors—AR—prostate cancer	0.00119	0.0113	CbGpPWpGaD
Dihydrotachysterol—VDR—Nuclear Receptors—RXRA—prostate cancer	0.00118	0.0112	CbGpPWpGaD
Dihydrotachysterol—VDR—Validated transcriptional targets of TAp63 isoforms—GADD45A—prostate cancer	0.00108	0.0103	CbGpPWpGaD
Dihydrotachysterol—VDR—Nuclear Receptor transcription pathway—ESR2—prostate cancer	0.00106	0.0101	CbGpPWpGaD
Dihydrotachysterol—VDR—Direct p53 effectors—GDF15—prostate cancer	0.00105	0.01	CbGpPWpGaD
Dihydrotachysterol—VDR—Validated transcriptional targets of TAp63 isoforms—NQO1—prostate cancer	0.00102	0.00976	CbGpPWpGaD
Dihydrotachysterol—VDR—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARA—prostate cancer	0.000984	0.00939	CbGpPWpGaD
Dihydrotachysterol—Alfacalcidol—VDR—prostate cancer	0.00097	0.116	CrCbGaD
Dihydrotachysterol—Calcidiol—VDR—prostate cancer	0.00097	0.116	CrCbGaD
Dihydrotachysterol—Calcipotriol—VDR—prostate cancer	0.00097	0.116	CrCbGaD
Dihydrotachysterol—VDR—Regulation of nuclear SMAD2/3 signaling—ATF3—prostate cancer	0.000968	0.00924	CbGpPWpGaD
Dihydrotachysterol—VDR—Nuclear Receptors—NR3C1—prostate cancer	0.00096	0.00917	CbGpPWpGaD
Dihydrotachysterol—VDR—Ovarian Infertility Genes—ATM—prostate cancer	0.000943	0.00901	CbGpPWpGaD
Dihydrotachysterol—VDR—Nuclear Receptor transcription pathway—AR—prostate cancer	0.000938	0.00896	CbGpPWpGaD
Dihydrotachysterol—VDR—Validated transcriptional targets of deltaNp63 isoforms—BRCA2—prostate cancer	0.000931	0.00889	CbGpPWpGaD
Dihydrotachysterol—VDR—Nuclear Receptor transcription pathway—RXRA—prostate cancer	0.000931	0.00889	CbGpPWpGaD
Dihydrotachysterol—VDR—Nuclear Receptors—PPARA—prostate cancer	0.0009	0.00859	CbGpPWpGaD
Dihydrotachysterol—VDR—Direct p53 effectors—TNFRSF10A—prostate cancer	0.000871	0.00831	CbGpPWpGaD
Dihydrotachysterol—VDR—Direct p53 effectors—NDRG1—prostate cancer	0.000871	0.00831	CbGpPWpGaD
Dihydrotachysterol—Paricalcitol—VDR—prostate cancer	0.000865	0.103	CrCbGaD
Dihydrotachysterol—Calcitriol—VDR—prostate cancer	0.000865	0.103	CrCbGaD
Dihydrotachysterol—VDR—Retinoic acid receptors-mediated signaling—CREBBP—prostate cancer	0.000863	0.00824	CbGpPWpGaD
Dihydrotachysterol—VDR—RXR and RAR heterodimerization with other nuclear receptor—BCL2—prostate cancer	0.000835	0.00797	CbGpPWpGaD
Dihydrotachysterol—VDR—Nuclear Receptors—ESR1—prostate cancer	0.000815	0.00778	CbGpPWpGaD
Dihydrotachysterol—VDR—Regulation of nuclear SMAD2/3 signaling—NCOA2—prostate cancer	0.000802	0.00766	CbGpPWpGaD
Dihydrotachysterol—VDR—Direct p53 effectors—CASP6—prostate cancer	0.000776	0.00741	CbGpPWpGaD
Dihydrotachysterol—VDR—Validated transcriptional targets of TAp63 isoforms—BAX—prostate cancer	0.000764	0.00729	CbGpPWpGaD
Dihydrotachysterol—VDR—Nuclear Receptor transcription pathway—NR3C1—prostate cancer	0.000759	0.00725	CbGpPWpGaD
Dihydrotachysterol—Calcipotriol—MPO—prostate cancer	0.000722	0.0861	CrCbGaD
Dihydrotachysterol—VDR—Nuclear Receptor transcription pathway—PPARA—prostate cancer	0.000711	0.00679	CbGpPWpGaD
Dihydrotachysterol—VDR—Direct p53 effectors—CX3CL1—prostate cancer	0.000696	0.00665	CbGpPWpGaD
Dihydrotachysterol—VDR—Validated transcriptional targets of deltaNp63 isoforms—ATM—prostate cancer	0.000694	0.00662	CbGpPWpGaD
Dihydrotachysterol—Ergocalciferol—VDR—prostate cancer	0.000691	0.0824	CrCbGaD
Dihydrotachysterol—VDR—Generic Transcription Pathway—ZNF160—prostate cancer	0.000691	0.0066	CbGpPWpGaD
Dihydrotachysterol—VDR—Regulation of nuclear SMAD2/3 signaling—NCOA1—prostate cancer	0.000676	0.00645	CbGpPWpGaD
Dihydrotachysterol—VDR—Regulation of nuclear SMAD2/3 signaling—AR—prostate cancer	0.000648	0.00619	CbGpPWpGaD
Dihydrotachysterol—VDR—Nuclear Receptor transcription pathway—ESR1—prostate cancer	0.000644	0.00615	CbGpPWpGaD
Dihydrotachysterol—VDR—Ovarian Infertility Genes—CDKN1B—prostate cancer	0.000636	0.00607	CbGpPWpGaD
Dihydrotachysterol—VDR—Direct p53 effectors—TGFA—prostate cancer	0.00063	0.00601	CbGpPWpGaD
Dihydrotachysterol—VDR—Direct p53 effectors—ATF3—prostate cancer	0.000625	0.00597	CbGpPWpGaD
Dihydrotachysterol—VDR—Validated transcriptional targets of deltaNp63 isoforms—GSK3B—prostate cancer	0.000624	0.00596	CbGpPWpGaD
Dihydrotachysterol—VDR—Direct p53 effectors—IGFBP3—prostate cancer	0.000588	0.00562	CbGpPWpGaD
Dihydrotachysterol—VDR—Retinoic acid receptors-mediated signaling—EP300—prostate cancer	0.000588	0.00561	CbGpPWpGaD
Dihydrotachysterol—VDR—RXR and RAR heterodimerization with other nuclear receptor—TGFB1—prostate cancer	0.000573	0.00547	CbGpPWpGaD
Dihydrotachysterol—VDR—Direct p53 effectors—MLH1—prostate cancer	0.000568	0.00542	CbGpPWpGaD
Dihydrotachysterol—VDR—Regulation of nuclear SMAD2/3 signaling—IL10—prostate cancer	0.000567	0.00541	CbGpPWpGaD
Dihydrotachysterol—VDR—Direct p53 effectors—CTSD—prostate cancer	0.000543	0.00519	CbGpPWpGaD
Dihydrotachysterol—VDR—Regulation of nuclear SMAD2/3 signaling—NR3C1—prostate cancer	0.000524	0.005	CbGpPWpGaD
Dihydrotachysterol—Cholecalciferol—VDR—prostate cancer	0.000524	0.0624	CrCbGaD
Dihydrotachysterol—VDR—Validated transcriptional targets of deltaNp63 isoforms—MDM2—prostate cancer	0.000512	0.00489	CbGpPWpGaD
Dihydrotachysterol—VDR—Direct p53 effectors—GADD45A—prostate cancer	0.000502	0.00479	CbGpPWpGaD
Dihydrotachysterol—Ergocalciferol—AR—prostate cancer	0.000501	0.0598	CrCbGaD
Dihydrotachysterol—VDR—Generic Transcription Pathway—TBX5—prostate cancer	0.000479	0.00457	CbGpPWpGaD
Dihydrotachysterol—VDR—Direct p53 effectors—HSPA1A—prostate cancer	0.000474	0.00452	CbGpPWpGaD
Dihydrotachysterol—VDR—Validated transcriptional targets of TAp63 isoforms—MDM2—prostate cancer	0.000458	0.00437	CbGpPWpGaD
Dihydrotachysterol—VDR—Regulation of nuclear SMAD2/3 signaling—ESR1—prostate cancer	0.000445	0.00425	CbGpPWpGaD
Dihydrotachysterol—VDR—Regulation of nuclear SMAD2/3 signaling—CREBBP—prostate cancer	0.00039	0.00372	CbGpPWpGaD
Dihydrotachysterol—VDR—Validated transcriptional targets of TAp63 isoforms—CDKN1A—prostate cancer	0.000386	0.00369	CbGpPWpGaD
Dihydrotachysterol—VDR—Validated transcriptional targets of TAp63 isoforms—EP300—prostate cancer	0.000367	0.00351	CbGpPWpGaD
Dihydrotachysterol—VDR—Regulation of nuclear SMAD2/3 signaling—SERPINE1—prostate cancer	0.000366	0.00349	CbGpPWpGaD
Dihydrotachysterol—VDR—Direct p53 effectors—BAX—prostate cancer	0.000356	0.0034	CbGpPWpGaD
Dihydrotachysterol—VDR—Retinoic acid receptors-mediated signaling—AKT1—prostate cancer	0.000355	0.00339	CbGpPWpGaD
Dihydrotachysterol—VDR—Gene Expression—BAZ2A—prostate cancer	0.000333	0.00318	CbGpPWpGaD
Dihydrotachysterol—VDR—Gene Expression—ZNF160—prostate cancer	0.000333	0.00318	CbGpPWpGaD
Dihydrotachysterol—VDR—Gene Expression—SSR2—prostate cancer	0.000333	0.00318	CbGpPWpGaD
Dihydrotachysterol—VDR—Direct p53 effectors—BCL2L1—prostate cancer	0.000309	0.00295	CbGpPWpGaD
Dihydrotachysterol—VDR—Gene Expression—HNRNPH1—prostate cancer	0.000304	0.0029	CbGpPWpGaD
Dihydrotachysterol—VDR—Direct p53 effectors—CAV1—prostate cancer	0.000298	0.00285	CbGpPWpGaD
Dihydrotachysterol—VDR—Gene Expression—NFIC—prostate cancer	0.000283	0.0027	CbGpPWpGaD
Dihydrotachysterol—VDR—Regulation of nuclear SMAD2/3 signaling—CDKN1A—prostate cancer	0.000279	0.00267	CbGpPWpGaD
Dihydrotachysterol—VDR—Direct p53 effectors—APC—prostate cancer	0.000272	0.00259	CbGpPWpGaD
Dihydrotachysterol—VDR—Gene Expression—RPN2—prostate cancer	0.000266	0.00254	CbGpPWpGaD
Dihydrotachysterol—VDR—Regulation of nuclear SMAD2/3 signaling—EP300—prostate cancer	0.000266	0.00254	CbGpPWpGaD
Dihydrotachysterol—VDR—Generic Transcription Pathway—NPPA—prostate cancer	0.000256	0.00244	CbGpPWpGaD
Dihydrotachysterol—VDR—Gene Expression—QARS—prostate cancer	0.000252	0.00241	CbGpPWpGaD
Dihydrotachysterol—VDR—Direct p53 effectors—CREBBP—prostate cancer	0.000252	0.0024	CbGpPWpGaD
Dihydrotachysterol—VDR—Generic Transcription Pathway—MED12—prostate cancer	0.000252	0.0024	CbGpPWpGaD
Dihydrotachysterol—Calcitriol—CYP3A4—prostate cancer	0.000247	0.0294	CrCbGaD
Dihydrotachysterol—Paricalcitol—CYP3A4—prostate cancer	0.000247	0.0294	CrCbGaD
Dihydrotachysterol—VDR—Direct p53 effectors—MMP2—prostate cancer	0.000241	0.0023	CbGpPWpGaD
Dihydrotachysterol—VDR—Direct p53 effectors—SERPINE1—prostate cancer	0.000236	0.00225	CbGpPWpGaD
Dihydrotachysterol—Cholecalciferol—CYP2C19—prostate cancer	0.000235	0.028	CrCbGaD
Dihydrotachysterol—Cholecalciferol—CYP1A1—prostate cancer	0.000234	0.0279	CrCbGaD
Dihydrotachysterol—VDR—Regulation of nuclear SMAD2/3 signaling—MYC—prostate cancer	0.000231	0.00221	CbGpPWpGaD
Dihydrotachysterol—VDR—Gene Expression—TBX5—prostate cancer	0.000231	0.0022	CbGpPWpGaD
Dihydrotachysterol—VDR—Direct p53 effectors—BCL2—prostate cancer	0.000217	0.00207	CbGpPWpGaD
Dihydrotachysterol—VDR—Gene Expression—EIF3H—prostate cancer	0.000214	0.00205	CbGpPWpGaD
Dihydrotachysterol—VDR—Direct p53 effectors—MDM2—prostate cancer	0.000214	0.00204	CbGpPWpGaD
Dihydrotachysterol—VDR—Generic Transcription Pathway—NCOA2—prostate cancer	0.000201	0.00192	CbGpPWpGaD
Dihydrotachysterol—Ergocalciferol—CYP3A4—prostate cancer	0.000197	0.0235	CrCbGaD
Dihydrotachysterol—VDR—Generic Transcription Pathway—PARP1—prostate cancer	0.000194	0.00185	CbGpPWpGaD
Dihydrotachysterol—VDR—Generic Transcription Pathway—ESR2—prostate cancer	0.000184	0.00175	CbGpPWpGaD
Dihydrotachysterol—VDR—Direct p53 effectors—CDKN1A—prostate cancer	0.00018	0.00172	CbGpPWpGaD
Dihydrotachysterol—VDR—Direct p53 effectors—PTEN—prostate cancer	0.00018	0.00172	CbGpPWpGaD
Dihydrotachysterol—VDR—Gene Expression—MBD2—prostate cancer	0.000175	0.00167	CbGpPWpGaD
Dihydrotachysterol—VDR—Gene Expression—TET2—prostate cancer	0.000175	0.00167	CbGpPWpGaD
Dihydrotachysterol—VDR—Direct p53 effectors—EP300—prostate cancer	0.000171	0.00164	CbGpPWpGaD
Dihydrotachysterol—VDR—Gene Expression—RPL12—prostate cancer	0.000171	0.00164	CbGpPWpGaD
Dihydrotachysterol—VDR—Generic Transcription Pathway—NCOA1—prostate cancer	0.000169	0.00161	CbGpPWpGaD
Dihydrotachysterol—VDR—Generic Transcription Pathway—AR—prostate cancer	0.000162	0.00155	CbGpPWpGaD
Dihydrotachysterol—VDR—Generic Transcription Pathway—RXRA—prostate cancer	0.000161	0.00154	CbGpPWpGaD
Dihydrotachysterol—VDR—Regulation of nuclear SMAD2/3 signaling—AKT1—prostate cancer	0.000161	0.00153	CbGpPWpGaD
Dihydrotachysterol—VDR—Gene Expression—EIF3A—prostate cancer	0.000157	0.0015	CbGpPWpGaD
Dihydrotachysterol—Cholecalciferol—CYP3A4—prostate cancer	0.000149	0.0178	CrCbGaD
Dihydrotachysterol—VDR—Direct p53 effectors—EGFR—prostate cancer	0.000146	0.0014	CbGpPWpGaD
Dihydrotachysterol—VDR—Gene Expression—DNMT3B—prostate cancer	0.000132	0.00126	CbGpPWpGaD
Dihydrotachysterol—VDR—Generic Transcription Pathway—NR3C1—prostate cancer	0.000131	0.00125	CbGpPWpGaD
Dihydrotachysterol—VDR—Gene Expression—RPL10—prostate cancer	0.00013	0.00124	CbGpPWpGaD
Dihydrotachysterol—VDR—Gene Expression—HIST1H2BG—prostate cancer	0.000127	0.00122	CbGpPWpGaD
Dihydrotachysterol—VDR—Gene Expression—HIST1H4H—prostate cancer	0.000123	0.00118	CbGpPWpGaD
Dihydrotachysterol—VDR—Gene Expression—NPPA—prostate cancer	0.000123	0.00118	CbGpPWpGaD
Dihydrotachysterol—VDR—Generic Transcription Pathway—PPARA—prostate cancer	0.000123	0.00117	CbGpPWpGaD
Dihydrotachysterol—VDR—Direct p53 effectors—TP53—prostate cancer	0.000123	0.00117	CbGpPWpGaD
Dihydrotachysterol—VDR—Gene Expression—MED12—prostate cancer	0.000121	0.00116	CbGpPWpGaD
Dihydrotachysterol—VDR—Generic Transcription Pathway—ESR1—prostate cancer	0.000111	0.00106	CbGpPWpGaD
Dihydrotachysterol—VDR—Gene Expression—RPS19—prostate cancer	0.000103	0.000983	CbGpPWpGaD
Dihydrotachysterol—VDR—Gene Expression—DNMT1—prostate cancer	9.84e-05	0.00094	CbGpPWpGaD
Dihydrotachysterol—VDR—Generic Transcription Pathway—CREBBP—prostate cancer	9.75e-05	0.000931	CbGpPWpGaD
Dihydrotachysterol—VDR—Gene Expression—NCOA2—prostate cancer	9.66e-05	0.000922	CbGpPWpGaD
Dihydrotachysterol—VDR—Gene Expression—EZH2—prostate cancer	9.53e-05	0.00091	CbGpPWpGaD
Dihydrotachysterol—VDR—Gene Expression—PARP1—prostate cancer	9.33e-05	0.000891	CbGpPWpGaD
Dihydrotachysterol—VDR—Generic Transcription Pathway—SERPINE1—prostate cancer	9.15e-05	0.000873	CbGpPWpGaD
Dihydrotachysterol—VDR—Gene Expression—ESR2—prostate cancer	8.84e-05	0.000843	CbGpPWpGaD
Dihydrotachysterol—VDR—Gene Expression—HSPA1A—prostate cancer	8.84e-05	0.000843	CbGpPWpGaD
Dihydrotachysterol—VDR—Gene Expression—NCOA1—prostate cancer	8.14e-05	0.000777	CbGpPWpGaD
Dihydrotachysterol—VDR—Gene Expression—AR—prostate cancer	7.8e-05	0.000745	CbGpPWpGaD
Dihydrotachysterol—VDR—Gene Expression—RXRA—prostate cancer	7.74e-05	0.000739	CbGpPWpGaD
Dihydrotachysterol—VDR—Gene Expression—SIRT1—prostate cancer	7.12e-05	0.000679	CbGpPWpGaD
Dihydrotachysterol—VDR—Gene Expression—ERCC2—prostate cancer	6.41e-05	0.000612	CbGpPWpGaD
Dihydrotachysterol—VDR—Gene Expression—NR3C1—prostate cancer	6.31e-05	0.000603	CbGpPWpGaD
Dihydrotachysterol—VDR—Gene Expression—PPARA—prostate cancer	5.91e-05	0.000565	CbGpPWpGaD
Dihydrotachysterol—VDR—Generic Transcription Pathway—MYC—prostate cancer	5.79e-05	0.000553	CbGpPWpGaD
Dihydrotachysterol—VDR—Gene Expression—ESR1—prostate cancer	5.36e-05	0.000512	CbGpPWpGaD
Dihydrotachysterol—VDR—Gene Expression—CREBBP—prostate cancer	4.7e-05	0.000448	CbGpPWpGaD
Dihydrotachysterol—VDR—Gene Expression—SERPINE1—prostate cancer	4.4e-05	0.00042	CbGpPWpGaD
Dihydrotachysterol—VDR—Gene Expression—MYC—prostate cancer	2.79e-05	0.000266	CbGpPWpGaD
Dihydrotachysterol—VDR—Gene Expression—AKT1—prostate cancer	1.93e-05	0.000185	CbGpPWpGaD
